News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Two top-cited 2023 papers on Annals Of Oncology – ESMO
David Miles and Juan Pascual
Dec 5, 2024, 15:37

Two top-cited 2023 papers on Annals Of Oncology – ESMO

ESMO shared on LinkedIn:

“As Annals Of Oncology 35th Anniversary is commemorated, here are two top-cited 2023 papers:

‘Primary results from IMpassion131: Paclitaxel with or without atezolizumab for triple-negative breast cancer’

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

Authors: D. Miles, J. Gligorov, F. André, D. Cameron, A. Schneeweiss, C. Barrios, B. Xu, A. Wardley, D. Kaen, L. Andrade,  V. Semiglazov, M. Reinisch, S. Patel, M. Patre, L. Morales, S.L. Patel, M. Kaul, T. Barata, J. O’Shaughnessy

Annals Of Oncology

‘ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer’

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Authors: J. Pascual, G. Attard, F.-C. Bidard, G. Curigliano, L. De Mattos-Arruda, M. Diehn, A. Italiano, J. Lindberg, J.D. Merker, C. Montagut, N. Normanno, K. Pantel, G. Pentheroudakis, S. Popat, J.S. Reis-Filho, J. Tie, J. Seoane, N. Tarazona, T. Yoshino, N.C. Turner

Annals Of Oncology

A. Italiano A. Schneeweiss A. Wardley Annals of Oncology B. Xu C. Barrios C. Montagut cancer D. Cameron D. Kaen D. Miles ESMO F. André F.-C. Bidard G Curigliano G Pentheroudakis G. Attard J. Gligorov J. Lindberg J. O’Shaughnessy J. Pascual J. Seoane J. Tie J.D. Merker J.S. Reis-Filho K. Pantel L. Andrade L. De Mattos-Arruda L. Morales M. Diehn M. Kaul M. Patre M. Reinisch N. Normanno N. Tarazona N.C. Turner OncoDaily Oncology S. Patel S. Popat S.L. Patel T. Barata T. Yoshino V. Semiglazov
Special Coverage
Blog
Dec 5, 2024, 15:38
Samson W. Fine: 2024 HCW vs Hunger closing in on $600K
Insight
Dec 5, 2024, 15:37
Two top-cited 2023 papers on Annals Of Oncology - ESMO
Blog
Dec 5, 2024, 15:32
Impact of an AYA Cancer Program on Enhancing Cancer Care Delivery
Blog
Dec 5, 2024, 15:28
Sylvie Leotin will give a Grand Rounds lecture at the Yale Cancer Center
Insight
Dec 5, 2024, 15:28
Christian Rolfo: Bintrafusp Alfa Plus Chemotherapy in Patients With Stage IV NSCLC
Insight
Dec 5, 2024, 15:27
Eduardo Bruera: Coping Strategies and Symptom Burden in Advanced Cancer Patients
Blog
Dec 5, 2024, 15:23
Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC
Insight
Dec 5, 2024, 15:21
Timothée Olivier: NATALEE trial - 3 years of adjuvant ribociclib in early breast cancer
Blog
Dec 5, 2024, 15:18
Matteo Lambertini: The use of genomic testing in early HR+/HER2- disease
Blog
Dec 5, 2024, 15:16
Aakash Desai: Phase I Results for AMG 193 
Blog
Dec 5, 2024, 15:11
Douglas Flora is a speaker at Total Health’s 10th Annual West Oncology Conference
Drugs
Dec 5, 2024, 15:08
Tranexamic acid among patients with haematological malignancies and severe thrombocytopenia - The Lancet Haematology